Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
pasquale.pignatelli@uniroma1.it
Pasquale Pignatelli
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
pasquale.pignatelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention
THE AMERICAN JOURNAL OF CARDIOLOGY
2020
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis
SEMINARS IN ARTHRITIS AND RHEUMATISM
2020
Is Albumin Predictor of Mortality in COVID-19?
ANTIOXIDANTS & REDOX SIGNALING
2020
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
BMJ OPEN
2020
Letter by violi et al regarding article, "rivaroxaban reduces arterial thrombosis by inhibition of fxa-driven platelet activation via protease activated receptor-1"
CIRCULATION RESEARCH
2020
Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin
BIOCHEMICAL PHARMACOLOGY
2019
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study
MAYO CLINIC PROCEEDINGS
2019
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2019
Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review
JOURNAL OF ALZHEIMER'S DISEASE
2019
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach
FRONTIERS IN CARDIOVASCULAR MEDICINE
2019
Update and unmet needs on the use of nonvitamin k Oral anticoagulants for stroke prevention in patients with atrial fibrillation
CURRENT PROBLEMS IN CARDIOLOGY
2019
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. a systematic review and bayesian meta-regression analysis
AUTOIMMUNITY REVIEWS
2019
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study
THE AMERICAN JOURNAL OF MEDICINE
2019
Silybin and metabolic disorders
INTERNAL AND EMERGENCY MEDICINE
2019
Antiplatelet treatment in acute coronary syndrome patients. real-world data from the START-Antiplatelet italian registry
PLOS ONE
2019
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort
ATHEROSCLEROSIS
2019
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study
FRONTIERS IN ENDOCRINOLOGY
2019
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation
MAYO CLINIC PROCEEDINGS
2019
Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion?
ANTIOXIDANTS & REDOX SIGNALING
2019
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
ERC
LS1_2
LS1_5
LS2_16
LS3
LS4
LS4_3
LS4_7
LS4_10
LS8_4
Keywords
Modulation of Oxidative Stress
Platelets
Atherothrombosis
Thrombosis
Progetti di Ricerca
The role of gut permeability in patients with cardiovascular disease
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9), PLATELET ACTIVATION AND RISK OF CARDIOVASCULAR EVENTS IN ATRIAL FIBRILLATION
PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation.
PCSK9 e attivazione piastrinica: implicazioni nei pazienti con fibrillazione atriale
Gruppi di ricerca
Cardiologia geriatrica
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma